Association of cytokine and toll-like receptor gene polymorphisms with severe malaria in three regions of cameroon

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Apinjoh, Tobias O ^a   Anchang Kimbi, Judith K ^a   Njua Yafi, Clarisse ^b   Mugri, Regina N ^a   Ngwai, Andre N ^a   Rockett, Kirk A ^c,d   Mbunwe, Eric ^a,e   Besingi, Richard N ^a,f   Clark, Taane G ^g   Kwiatkowski, Dominic P ^c,d   Achidi, Eric A ^a  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e DIABETES RESEARCH CENTER   (Belgium)

^f UNIVERSITY OF FLORIDA   (United States)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CAMEROON; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 84894265837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081071     Document Type: Article

References (65)

1. World Health Organisation (2012). World Malaria Report 2012. Available: http://www.who.int/malaria/publications/world-malaria-report-2012/report/en/ index.html. Accessed 2013 June 08
2. Malaria GEN (2008) A global network for investigating the genomic epidemiology of malaria. Nature 456: 732-738. doi:10.1038/nature07632. PubMed: 19079050.
3. Stevenson MM, Riley EM (2004) Innate immunity to malaria. Nat Rev Immunol 4: 169-180. doi:10.1038/nri1311. PubMed: 15039754.
4. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN (2005) Heritability of malaria in Africa. PLoS Med 2: e340. doi:10.1371/journal.pmed. 0020340. PubMed: 16259530.
5. Langhorne J, Ndungu FM, Sponaas AM, Marsh K (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732. doi:10.1038/ni.f.205. PubMed: 18563083.
6. Kurtzhals JA, Akanmori BD, Goka BQ, Adabayeri V, Nkrumah FK et al. (1999) The cytokine balance in severe malarial anemia. J Infect Dis 180: 1753-1755. doi:10.1086/315077. PubMed: 10515852.
7. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS et al. (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 179: 279-282. doi:10.1086/314548. PubMed: 9841855.
8. Ouma C, Davenport GC, Were T, Otieno MF, Hittner JB et al. (2008) Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet 124: 515-524. doi:10.1007/s00439-008-0578-5. PubMed: 18972133.
9. Achidi EA, Apinjoh TO, Yafi CN, Besingi R, Anchang JK, et al. (2013) Plasma Levels of Tumour Necrosis Factor-Alpha, Interleukin-10, Interleukin-12, Macrophage Inhibition Factor and Transforming Growth Factor-Beta in Children with Severe and Uncomplicated Falciparum Malaria. J Trop Dis 1: 103.
10. Cramer JP, Mockenhaupt FP, Ehrhardt S, Burkhardt J, Otchwemah RN et al. (2004) iNOS promoter variants and severe malaria in Ghanaian children. Trop Med Int Health 9: 1074-1080. doi:10.1111/j.1365-3156.2004.01312.x.
11. Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5: 315-329. doi:10.1038/sj.gene.6364055. PubMed: 14973548.
12. Carpenter D, Abushama H, Bereczky S, Färnert A, Rooth I et al. (2007) Immunogenetic control of antibody responsiveness in a malaria endemic area. Hum Immunol 68: 165-169. doi:10.1016/j.humimm.2006.12.002. PubMed: 17349871.
13. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N et al. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 22: 145-150. doi:10.1038/9649. PubMed: 10369255.
14. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM et al. (1999) Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 179: 287-290. doi:10.1086/314533. PubMed: 9841857.
15. Clark TG, Diakite M, Auburn S, Campino S, Fry AE et al. (2009) Tumor Necrosis Factor and Lymphotoxin-Alpha Polymorphisms and Severe Malaria in African Populations. J Infect Dis 199: 569-575. doi:10.1086/596320. PubMed: 19281305.
16. Diakite M, Clark TG, Auburn S, Campino SG, Fry AE et al. (2009) A genetic association study in The Gambia using tagging polymorphisms in the major histocompatibility complex (MHC) class III region implicates a HLA-B associated transcript 2 (BAT2) polymorphism in severe malaria susceptibility. Hum Genet 125: 105-109. doi:10.1007/s00439-008-0597-2. PubMed: 19039607.
17. Ackerman HC, Ribas G, Jallow M, Mott R, Neville M et al. (2003) Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun 4: 476-486. doi:10.1038/sj.gene.6364008. PubMed: 14551600.
18. Kwiatkowski DP (2005) How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77: 171-192. doi:10.1086/432519. PubMed: 16001361.
19. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ et al. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8. doi:10.1111/j.1365-2370.1997.tb00001.x.
20. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW et al. (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 66: 3915-3922.
21. Wilson JN, Rockett K, Jallow M, Pinder M, Sisay-Joof F et al. (2005) Analysis of IL10 haplotypic associations with severe malaria. Genes Immun 6: 462-466. doi:10.1038/sj.gene.6364227. PubMed: 15933743.
22. Westendorp RG, van Dunne FM, Kirkwood TB, Helmerhorst FM, Huizinga TW (2001) Optimizing human fertility and survival. Nat Med 7: 873. doi:10.1038/90868. PubMed: 11479599.
23. Koch O, Rockett K, Jallow M, Pinder M, Sisay-Joof F et al. (2005) Investigation of malaria susceptibility determinants in the IFNG/IL26/IL22 genomic region. Genes Immun 6: 312-318. doi:10.1038/sj.gene.6364214. PubMed: 15858598.
24. Walley AJ, Aucan C, Kwiatkowski D, Hill AV (2004) Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur J Hum Genet 12: 132-138. doi:10.1038/sj.ejhg.5201084. PubMed: 14673470.
25. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S et al. (2005) Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280: 8606-8616. PubMed: 15623512.
26. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J et al. (2006a) Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sciences U-S-A, 103: 177-182. doi:10.1073/pnas.0506803102. PubMed: 1737335516371473.
27. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C et al. (2006b) Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 194: 184-188. doi:10.1086/505152. PubMed: 16779724.
28. Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S et al. (2004) Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 172: 4926-4933. PubMed: 15067072.
29. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S et al. (2005) Toll-like receptor 9 mediates innate immune activation by the malaria pigment haemozoin. J Exp Med 201: 19-25. doi:10.1084/jem.20041836. PubMed: 15630134.
30. Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L et al. (2008) Malaria Parasites Require TLR9 Signaling for Immune Evasion by Activating Regulatory T Cells. J Immunol 180: 2496-2503. PubMed: 18250459.
31. Schröder NWJ, Schumann RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5: 156-164. doi:10.1016/S1473-3099(05)70023-2. PubMed: 15766650.
32. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191. doi:10.1038/76048. PubMed: 10835634.
33. Cook DN, Pisetsky DS, Schwartz DA (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5: 975-979. doi:10.1038/ni1116. PubMed: 15454920.
34. Lorenz E, Mira JP, Frees KL, Schwartz DA (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162: 1028-1032. doi:10.1001/archinte.162.9.1028. PubMed: 11996613.
35. Read RC, Pullin J, Gregory S, Borrow R, Kaczmarski EB et al. (2001) A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 184: 640-642. doi:10.1086/322798. PubMed: 11494169.
36. Smirnova I, Mann N, Dols A, Derkx HH, Hibberd ML et al. (2003) Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A 100: 6075-6080. doi:10.1073/pnas.1031605100. PubMed: 12730365.
37. Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R et al. (2004) Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 116: 152-156. doi:10.1016/j.ejogrb.2004.02.010. PubMed: 15358455.
38. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ et al. (2003) Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 81: 85-91. doi:10.1016/S0888-7543(02)00022-8. PubMed: 12573264.
39. Török HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M et al. (2004) Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127: 365-366. doi:10.1053/j.gastro.2004.05.051. PubMed: 15236225.
40. Leoratti FM, Farias L, Alves FP, Suarez-Mútis MC, Coura JR et al. (2008) Variants in the Toll-Like Receptor Signaling Pathway and Clinical Outcomes of Malaria. J Infect Dis 198: 772-780. doi:10.1086/590440. PubMed: 18662133.
41. Campino S, Forton J, Auburn S, Fry A, Diakite M et al. (2009) TLR9 polymorphisms in African populations: no association with severe malaria, but evidence of cis-variants acting on gene expression. Malar J 8: 44. doi:10.1186/1475-2875-8-44. PubMed: 19284650.
42. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P et al. (2009) Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 41: 657-665. doi:10.1038/ng.388. PubMed: 19465909.
43. Toure O, Konate S, Sissoko S, Niangaly A, Barry A et al. (2012) Candidate Polymorphisms and Severe Malaria in a Malian. Population - PLOS ONE 7: e43987. doi:10.1371/journal.pone.0043987.
44. Manjurano A, Clark TG, Nadjm B, Mtove G, Wangai H et al. (2012) Candidate Human Genetic Polymorphisms and Severe Malaria in a Tanzanian. Population - PLOS ONE 7: e47463. doi:10.1371/journal.pone.0047463.
45. Achidi EA, Apinjoh TO, Mbunwe E, Besingi R, Yafi C et al. (2008) Febrile status, malarial parasitaemia and gastro-intestinal helminthiases in school children resident at different altitudes, in south-western Cameroon. Ann Trop Med Parasitol 102: 103-118. doi:10.1179/136485908X252287. PubMed: 18318932.
46. Achidi EA, Apinjoh TO, Anchang-Kimbi JK, Mugri RN, Ngwai AN et al. (2012) Severe and uncomplicated falciparum malaria in children from three regions and three ethnic groups in Cameroon: prospective study. Malar J 11: 215. doi:10.1186/1475-2875-11-215. PubMed: 22727184.
47. World Health Organisation (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94: S1-S90. doi:10.1016/S0035-9203(00)90413-9. PubMed: 11103309.
48. Rooth I, Perlmann H, Bjorkman A (1991) Plasmodium falciparum reinfection in children from a holoendemic area in relation to seroreactivities against oligopeptides from different malarial antigens. Am J Trop Med Hyg 45: 309-318. PubMed: 1718179.
49. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W et al. (1992) Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A 89: 5847-5851. doi:10.1073/pnas.89.13.5847. PubMed: 1631067.
50. Ross P, Hall L, Smirnov I, Haff L (1998) High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 16: 1347-1351. doi:10.1038/4328. PubMed: 9853617.
51. Teo YY, Fry AE, Clark TG, Tai ES, Seielstad M (2007) On the usage of HWE for identifying genotyping errors. Ann Hum Genet 71: 701-704. doi:10.1111/j.1469-1809.2007.00356.x. PubMed: 17388941.
52. Rihet P, Traoré Y, Abel L, Aucan C, Traoré-Leroux T et al. (1998) Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 63: 498-505. doi:10.1086/301967. PubMed: 9683598.
53. Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V et al. (2004) Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin Exp Immunol 138: 145-150. doi:10.1111/j.1365-2249.2004.02590.x. PubMed: 15373917.
54. van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER et al. (1999) An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1: 61-65. doi:10.1038/sj.gene.6363630. PubMed: 11197307.
55. van der Pouw Kraan TC, Küçükaycan M, Bakker AM, Baggen JM, van der Zee JS et al. (2002) Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 3: 436-439. doi:10.1038/sj.gene.6363896. PubMed: 12424628.
56. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S et al. (2003) A single-nucleotide substitution from C to T at position-1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun 4: 528-531. doi:10.1038/sj.gene.6364010. PubMed: 14551608.
57. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8. doi:10.1111/j.1365-2370.1997.tb00001.x. PubMed: 9043871.
58. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-254. doi:10.1016/j.immuni.2004.07.007. PubMed: 15308104.
59. Ball TB, Ji H, Kimani J, McLaren P, Marlin C et al. (2007) Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21: 1091-1101. doi:10.1097/QAD. 0b013e3280ef6ae1. PubMed: 17502719.
60. Mangano VD, Luoni G, Rockett KA, Sirima BS, Konaté A et al. (2008) Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection. Genes Immun 9: 122-129. doi:10.1038/sj.gene. 6364456. PubMed: 18200030.
61. Mangano VD, Clark TG, Auburn S, Campino S, Diakite M et al. (2009) Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations. PLOS ONE 4: e4206. doi:10.1371/journal.pone.0004206. PubMed: 19145247.
62. Griffith JW, O'Connor C, Bernard K, Town T, Goldstein DR et al. (2007) Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis 196: 1553-1564. doi:10.1086/522865. PubMed: 18008236.
63. Zisman-Rozen S, Fink D, Ben-Izhak O, Fuchs Y, Brodski A et al. (2007) Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas. Oncogene 26: 6093-6098. doi:10.1038/sj.onc.1210424. PubMed: 17420726.
64. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC et al. (2007) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 6: 147. doi:10.1186/1475-2875-6-147. PubMed: 17997848.
65. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO et al. (2008) Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 7: 83. doi:10.1186/1475-2875-7-83. PubMed: 18489763.